Salarius Pharmaceuticals Investor Relations Material
Latest events
Q2 2022
Salarius Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Salarius Pharmaceuticals Inc
Access all reports
Salarius Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancers with unmet medical needs. The company specializes in epigenetic-based treatments, aiming to inhibit key cancer-related pathways and improve patient outcomes. The company is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Latest articles
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
SLRX
Country
πΊπΈ United States